Attention facilitates cognitive functions such as memory, language, problem solving, and perception optimal for goal-oriented behaviour. The ambient environment is a constant source of sensory stimulation in the form of sights, sounds, smells, temperature, and touch. To process all these stimuli continuously would be unnecessarily demanding upon a finite cognitive resource, as much of the information would be irrelevant to the task at hand. A crucial cognitive skill for survival is the ability to selectively process or disregard information from the abundance of sensory input enabling goal-directed behaviour to be achieved. The importance of attention is often overlooked as it does not localise anatomically and is therefore difficult to study. However, when impaired, the consequences can be devastating. This is evident in dementia with 
sensory input both overtly, in conjunction with eye movements, or covertly, in the absence of eye movements. It contextualises attentional focus so that specific information can be selected when presented with multiple competing sensory stimuli. The orienting of attention uses a network including the superior parietal cortex, temporoparietal cortex, frontal eye fields, pulvinar, and superior colliculus [9, 15] . Furthermore, impairments to orienting tasks were found following lesions to the basal forebrain systems of macaque monkeys [16] , implicating these areas in the orienting network. Orienting has been linked to activation of cholinergic pathways [17] , supported by research in rat brains that suggest acetylcholine, but not dopamine, is important for orienting tasks [18] .
Executive networks are called upon during tasks that require top-down attentional control and the ability to focus attention selectively according to task demands. Tasks involving selective planning, monitoring or inhibition of automatic responses produce subjective reports of mental exertion. During attention that is mentally exerting and conflict monitoring the anterior cingulate cortex is consistently activated [19] . Interestingly, this network may possess higher-level metacognitive properties, in other words, the network might be involved in generating the subjective impression of cognitive effort [20, 21] . It dynamically interacts with primary sensory regions via bottom-up signals, which subsequently enhance topdown modulation of sensory processing via a feedback mechanism [22] . Anatomically, the network of structures involved in executive attentional tasks includes the anterior cingulate cortex [23] , the medial frontal cortex [9] , lateral ventral prefrontal cortex, and basal ganglia. The influence of the mesocortical dopamine system on these areas implicates the neurotransmitter in executive attention.
When does attention break down?

Attention deficits in health
While individual differences make some people more prone to lapses in attention, age alone is a risk factor for mild attentional decline. Older people are slower to react during alerting tasks [24] and perform slower on executive attention tasks [25] , although orienting attention remains preserved with age [26] . There is debate about whether responding slowly to a target stimulus during an alerting task, a defining feature of age-related cognitive decline, is due to alterations in general processing speed or a selective deficit in an attentional domain [27] .
However, motor processing speed alone could not explain the executive deficits. Generalised slowing of cognitive processing speed probably represents a decline in the structural integrity of the white matter tracts and loss of brain volume, both of which progress with advancing age [28] .
We all suffer lapses in attention occasionally but there are situations when this can be detrimental. Hence the motivation for cognitive enhancement in healthy people is often when sustained vigilance taxing the alerting network is required, for example students at exam time, soldiers in battle or doctors on call. Prescription stimulant misuse by undergraduate American college students to enhance cognitive performance is well documented [29] . The incidence is estimated to be 3-10% with exam preparation cited as the most common reason [30] . The most commonly misused stimulants were methylphenidate, dextroamphetamin, methamphetamine and modafinil [31] . In cognitively normal individuals stimulants can improve attention, enhance consolidation of recently acquired information, reduce fatigue and the need for sleep [31, 32] . From is impaired following withdrawal [32] . of cases [33] . These two clinical syndromes differ in the sequence of onset of dementia and parkinsonism, but with progression both syndromes and underlying pathological changes become similar and can be viewed as a continuum rather than dichotomous entities.
Attention deficits in neurological disease
They are known under the umbrella term Lewy body dementias [34] .
Anecdotally, as clinicians we have seen people so profoundly affected by attention fluctuations that they are admitted to hospital with episodes of presumed loss of consciousness and investigated for epilepsy and other conditions. A breakdown in attentional function is thought to underpin the tendency to fluctuations, which may also contribute to the development of visual hallucinations through impaired bottom-up processing of sensory information that allows false data to be sent to the entire cortex and not be recognised as abnormal [35] . People with DLB struggle to attain the minimal activation of alertness needed for both attention and information processing to operate [36] . DLB patients also experience serious difficulties in drawing their attention to new relevant locations, suggesting their orienting attention is impaired [37] .
Executive dysfunction is an early, prominent neuropsychological feature [38] , thus failure of attention is a particular problem in this group with all networks affected [39] . DLB results from the accumulation of neuronal intracellular aggregates of α-synuclein, which form Lewy bodies, secondary cellular injury, and apoptotic neurodegeneration [40] . Pathologically, the 
Attention deficits in psychiatric disease
Enhancing attention with prescribed medications
Cholinesterase inhibitors (e.g., donepezil, galantamine, rivastigmine) were first introduced in 1997 and have now become the first line pharmacological treatment for AD and DLB [106, 107] . They work by inhibiting the breakdown of acetylcholine, an important neurotransmitter associated with memory, by blocking the enzyme acetylcholinesterase.
They improve scores on bedside cognitive tests (Mini-Mental State Examination) by a modest 5% over a 12 month period [108] . Whilst attention, working and episodic memory are improved, it is thought an increase in arousal, especially orienting attention, is the common pathway through which these effects are mediated [109] . Modafinil has been shown to directly bind to the dopamine transporter and to the noradrenaline transporter [113, 114] . This leads to significantly elevated extracellular dopamine, noradrenaline, serotonin, glutamate, and histamine levels, and to decreased γ-aminobutyric acid (GABA) levels [115] . Its neural dopaminergic effect is caused by blocking dopamine transporter proteins [116] .
Like other stimulants, it increases monoamine release, but also elevates hypothalamic histamine levels, and is therefore considered a 'wake-promoter' rather than an amphetamine-like stimulant [117] . Overall, modafinil is well tolerated, however there are growing case reports of precipitation or exacerbation of psychosis in patients with schizophrenia, narcolepsy and DLB. This is usually associated with doses higher than 200 mg/day or with co-administration of another stimulant, such as caffeine [118] .
Methylphenidate facilitates dopaminergic transmission by inhibiting the dopamine reuptake transporter and is the treatment of choice for ADHD [119] . It inhibits the plasma membrane catecholamine transporters, causing an increase of intrasynaptic dopamine and noradrenaline concentrations [120] .
Despite its use as a cognitive enhancer by
American college students it is not thought to improve cognition in those with a normal IQ and hence already close to an optimum level of dopamine [119] . It is important to note the effects of dopamine on cognition are often described to follow an inverted U-shaped curve in which intermediate levels of neurotransmitter activity lead to optimal cognitive performance but lower and higher levels may lead to suboptimal performance [109] and that dose-response relationships may vary between cognitive domains [121] . In healthy individuals methylphenidate improves working memory at a medium dose, and speed of processing at a low dose. Improvements in verbal memory, vigilance and executive function have been demonstrated less frequently [121] .
Unlike amphetamines, which increase both dopamine and noradrenaline levels in both the nucleus accumbens and the prefrontal cortex, atomoxetine is a selective noradrenaline transporter inhibitor that increases synaptic noradrenaline and dopamine levels in the prefrontal cortex only. The fact that atomoxetine does not increase dopamine levels in the nucleus accumbens (or other striatal regions) [122, 123] may explain the lower liability to abuse (compared to amphetamines) [124] . Clinically, it has been used with success in ADHD [125] , improving executive attention [126] but disappointingly efficacy has not be demonstrated in other conditions. Randomised controlled trials of participants with attention deficits following traumatic brain injury [127] , schizophrenia with cognitive decline [128] , and
Huntington's disease [129] did not yield any significant improvement with atomoxetine.
Histamine H 3 receptor antagonists are novel therapies in development to treat daytime somnolence [130] . Histaminergic complication, such as dyskinesias [138] . There is a slight preference for stimulating the STN over the GPi from a motor-efficacy perspective [139] . DBS also impacts on cognition at these sites; whilst there were no large differences in neuropsychological outcomes after stimulating the two areas, there was a greater negative change on orienting (Trail Making Test B) and executive (Stroop task) tasks of attention with STN stimulation [140] . Epilepsy patients treated with DBS of the bilateral anterior thalamic nuclei were assessed on computerised test of the executive attentional domain both on and off stimulation [141] . There were increased errors relating to lack of response inhibition and increased reaction times when distractors were used, during stimulation periods compared to when stimulation was turned off.
DBS is an exciting, emerging therapy for treating an expanding number of neurological and psychiatric disorders. However, to date very few studies have specifically assessed cognitive modulation as the primary outcome in patients with dementia [142] . A case report of bilateral DBS of the hypothalamus for appetite control in a morbidly obese man failed to achieve the intended outcome although a significant improvement in short term memory was observed [143] . It was hypothesised this 
